Noveome is a clinical-stage biopharmaceutical company advancing ST266 – a first-of-its-kind, multi-targeted, non-cellular novel biologic.
In this interactive session, you will learn about ST266 and it's potential to improve patients' outcomes across a range of challenging diseases and conditions. Happy hour with refreshments and light snacks will be served.
